LatestData & Analysis

I Stock 649569810
Data & Analysis

CVCA H1 Quarterly Exclusive: Top VC Deal Profile – Element AI

VC

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s most recently published VC & PE Canadian Market Overview through expert commentary and perspectives. Element AI Jumpstarts Canada’s AI Game Canada is capitalizing on the opportunity

I Stock 524452571
Data & Analysis

CVCA H1 Quarterly Exclusive: Behind Québec’s Booming Agri‑Forestry Industry

PE

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s most recently published VC & PE Canadian Market Overview through expert commentary and perspectives. Québec is advantaged with a natural environment that is attracting increasing private

I Stock 616903454
Data & Analysis

CVCA H1 Quarterly Exclusive: 2017: Active VC Investor Profile – Espresso Capital Ltd.

VC

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s most recently published VC & PE Canadian Market Overview through expert commentary and perspectives. “Our view of success isn’t how many home runs we back, it’s

I Stock 545378314
Data & Analysis

CVCA H1 Quarterly Exclusive: Active PE Investor Profile – Fondaction CSN

PE

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s most recently published VC & PE Canadian Market Overview through expert commentary and perspectives. “As a shareholder, Fondaction brings a huge amount of credibility and deep

I Stock 637229530
Data & Analysis

CVCA H1 Quarterly Exclusive: Top VC Deal Profile – Repare Therapeutics Inc.

VC

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s most recently published VC & PE Canadian Market Overview through expert commentary and perspectives. Versant Ventures Goes Behind-the-Scenes on the Second Largest VC Deal in H1

I Stock 539359546
Data & Analysis

CVCA H1 2017 Quarterly Exclusive: PE Market Bounces Back

PE

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s most recently published VC & PE Canadian Market Overview through expert commentary and perspectives. Compared to venture capital activity in Canada, private equity activity has more-or-less

CVCA Data Vis VCPE Canada H12017 Final14
Data & Analysis

CVCA H1 2017 Quarterly Exclusive: Behind the Robust Return of VC Exits

VC

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s most recently published VC & PE Canadian Market Overview through expert commentary and perspectives. Last year was undoubtedly a huge year for venture capital investment activity

CVCA Data Vis VCPE Canada H12017 Final26
Data & Analysis

CVCA H1 2017 Quarterly Exclusive: Rebound Year For PE Exits

PE

This article is part of a new series, CVCA Quarterly Exclusive, written and published by the Canadian Venture Capital and Private Equity Association. This series provides an analysis of the CVCA’s most recently published VC & PE Canadian Market Overview through expert commentary and perspectives. The recently released H1 2017 VC & PE Canadian Market Overview noted

I Stock 701117612
Data & Analysis

VC Investing: The Convergence of AI and Healthcare

VC

Quark Venture’s Partner & CEO weighs in on the future of AI and its role in the healthcare vertical There’s been plenty of media coverage lately about artificial intelligence. Most reporting has been generated through the vastly different views of people like Elon Musk the CEO of Tesla, SpaceX, and Neuralink, and Mark Zuckerberg, the

Psychology of a Deal 680x365px
Data & Analysis

Private Equity Deal Making: The Psychology Behind the Deal

PE

There’s no question there are certain predictors in any deal making process that can either enhance or erode the success of a deal. Generally speaking, that’s why the due diligence process is key—both for investors as well as the portfolio companies that they’re acquiring or investing in. And while the due diligence process is largely